On Target Laboratories
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$30M
On Target Laboratories develops and commercializes FDA-approved imaging agents for cancer surgeries, using near-infrared dye and targeting molecules to aid in detecting and resecting cancer cells.
Focus Areas
Biotechnology
Intraoperative Molecular Imaging Agents
Cancer Surgery
FDA-approved Imaging Agent
Cancer Cell Receptor Targeting
Disease Diagnosis
Investors
